Answers are grounded in this paper and cite their sources.
We detail the design and implementation of a plasmon-based colorimetric sensing strategy that can specifically evaluate the proteolytic activity of the Matrix Metalloproteinase-14 (MMP-14), a known early stage malignant disease biomarker. The approach leverages the high sensitivity of a localized Surface Plasmon Resonance (SPR) signature to track charge-mediated assembly between spherical gold nanoparticles (AuNPs), triggered by proteolysis of a zwitterion-modified peptide substrate, freeing cationic peptide fragments that readily self-assemble with anion presenting AuNPs. To achieve this, we have prepared Au nanocolloids surface-stabilized with an anionic-rich coating layer made of triphenylphosphine-3,3′,3″-trisulfonic acid trisodium salt, along with a charge-balanced zwitterion peptide that includes in its structure an amino acid sequence (substrate) specifically recognized by the enzyme. The peptide presents cationic and anionic fragments flanking the central substrate. The charge-mediated assembly of the AuNPs is promoted by specific recognition and proteolysis of the specific peptide substrate, which frees cation-rich peptide fragments, triggering nanoparticle aggregation and color change of the medium. This assembly results in a bathochromic shift of the SPR peak, providing a measurable signal that correlates with the concentration of MMP-14 and reaction time, allowing for the quantification of the proteolysis process. The assay is easy to implement and achieves a low limit of marker detection (∼1.5 nM).
No takes yet. Share an insight, caveat, or question.
Dridi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: